XAF1 and gastric cancer: Circulating methylated XAF1 DNA was associated with tumor burden and malignant progression, which may be a valuable biomarker for diagnosis of gastric cancer, predicting patients’ prognosis and monitoring tumor recurrence after surgery treatment.